Exchange: NASDAQ·Updated 06:52 AM EDT
KALA logo

KALA KALA BIO Inc

$0.5101
$0.0124
(2.37%)
Pre-Market
Prev Close $0.5225
Reported EarningsAug 8
Mkt Cap$10.29M
Vol68,545.00

About KALA

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
76

Extremely Bullish Sentiment

How do you feel about KALA?

Advertisement|Remove ads.